In our study, adiponectin levels in both plasma and pericardial fluid were higher in patients than in healthy controls, consistent with reports linking elevated adiponectin in CAD to worse outcomes and advanced disease [24,26]. The gene discussed is ADIPOQ; the disease is coronary artery disorder.